Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
The latest update is out from D-Wave Quantum ( (QBTS) ).
On January 22, 2025, D-Wave Quantum Inc. announced the launch of the Leap Quantum LaunchPad program, intended to accelerate the deployment of quantum computing applications. This initiative provides free trial access to D-Wave’s quantum technology and expertise, aiming to help customers utilize annealing quantum computing for complex business and scientific problems. The program is designed to facilitate the exploration and implementation of quantum applications, offering participants access to D-Wave’s annealing quantum computers and technical support for a three-month trial. The company also expanded access to its Quantum Programming Core and Quick Start Training programs, enhancing participants’ hands-on experience with quantum technology. This launch signifies D-Wave’s commitment to advancing quantum computing adoption and development, potentially impacting stakeholders by enabling the rapid deployment of transformative applications.
More about D-Wave Quantum
D-Wave Quantum Inc. is a leader in the development and delivery of quantum computing systems, software, and services. It is the world’s first commercial supplier of quantum computers, providing both annealing and gate-model quantum computers. D-Wave’s mission focuses on unlocking the power of quantum computing to benefit business and society, with applications across various fields including logistics, artificial intelligence, materials sciences, and more. The company serves advanced organizations globally and operates out of Palo Alto, CA, with a Quantum Center of Excellence near Vancouver, Canada.
YTD Price Performance: -34.55%
Average Trading Volume: 64,145,288
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $1.95B
See more insights into QBTS stock on TipRanks’ Stock Analysis page.